
Comend and Odylia Partner to Advance Rare Disease Drug Development with Innovative Patient-Driven Platform
The Comend and Odylia partnership provides new tools for patient groups to directly pursue drug development and drive investment in new treatments. ATLANTA, GA, UNITED STATES, May 13, 2025 /EINPresswire.com/ -- Comend, a software company …